| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/26/2002 | WO2002074741A1 Pyrrolidine ester derivatives with oxytocin modulating acitvity |
| 09/26/2002 | WO2002074327A2 Compositions and methods for treating gonadotrophin related illnesses |
| 09/26/2002 | WO2002074315A1 Pharmaceutical combined preparations containing aromatase inhibitors and substances having an estrogen effect in addition to the use thereof for producing a medicament for estrogen-replacement-therapy |
| 09/26/2002 | WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors |
| 09/26/2002 | WO2002074292A2 Hormone replacement therapy |
| 09/26/2002 | WO2002074288A2 Treatment and prevention of sexual dysfunction resulting from ssri-therapy by using a tetrahydrobenz cd indole-6-carboxamide |
| 09/26/2002 | WO2002074241A2 Method of delaying ejaculation |
| 09/26/2002 | WO2002074238A2 Water soluble and palatable complexes |
| 09/26/2002 | WO2002032461A3 Protein c or activated protein c-like molecules |
| 09/26/2002 | WO2002003975A3 Combinations of ssri and estrogenic agents |
| 09/26/2002 | WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 09/26/2002 | WO2001083775A3 Proteases |
| 09/26/2002 | WO2001076568A3 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 09/26/2002 | US20020138865 In vitro transfection, storage and transfer of male germ cells for generation of transgenic species & genetic therapies |
| 09/26/2002 | US20020138857 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 09/26/2002 | US20020137892 An isolated peptide transmitter-like receptor polypeptide with specific amino acid sequence or variant which has immunomodulatory, neuromodulatory and endocrinomodulatory activity |
| 09/26/2002 | US20020137763 (5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione |
| 09/26/2002 | US20020137755 Tyrosine kinase inhibitors |
| 09/26/2002 | US20020137749 Formulation for menopausal women |
| 09/26/2002 | US20020137664 Substituted piperidines as melanocortin-4 receptor agonists |
| 09/26/2002 | US20020137184 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and use thereof |
| 09/26/2002 | US20020137138 Modulating serotonin activity |
| 09/26/2002 | US20020137100 Method for determining the fertility of mammals, especially of humans |
| 09/26/2002 | US20020137086 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylation status of the genes |
| 09/26/2002 | US20020136715 Composition comprising a binding agent that specifically binds to circulating prostate specific antigen and induces a therapeutic immune response |
| 09/26/2002 | CA2758923A1 Use of tramadol to delay ejaculation |
| 09/26/2002 | CA2444526A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2441503A1 Method for cleaving human growth hormone gh |
| 09/26/2002 | CA2441152A1 Hormone replacement therapy |
| 09/26/2002 | CA2440631A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440475A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440002A1 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 09/26/2002 | CA2439528A1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors |
| 09/26/2002 | CA2436911A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors |
| 09/25/2002 | EP1243256A1 Vaccines absorbable by the transmucosal way |
| 09/25/2002 | EP1242590A2 Human lyases and associated proteins |
| 09/25/2002 | EP1242587A1 A NOVEL ISOFORM OF HUMAN cAMP-DEPENDENT PROTEIN KINASE, C ALPHA-s, LOCALIZES TO SPERM MIDPIECE AND THE USE THEREOF |
| 09/25/2002 | EP1242583A2 Human oxidoreductase proteins |
| 09/25/2002 | EP1242455A1 N-alkylated peptides having antiangiogenic activity |
| 09/25/2002 | EP1242445A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds |
| 09/25/2002 | EP1242422A1 Tricyclic dihydropyrimidine potassium channel openers |
| 09/25/2002 | EP1242415A1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242407A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242404A1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 09/25/2002 | EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242389A2 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 09/25/2002 | EP1242371A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242103A1 Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof |
| 09/25/2002 | EP1242083A1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 09/25/2002 | EP1242068A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 09/25/2002 | EP1242012A1 Improved transdermal contraceptive delivery system and process |
| 09/25/2002 | EP1242009A1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds |
| 09/25/2002 | EP1241935A2 Methods for producing transgenic animals |
| 09/25/2002 | EP1070059B1 Chromanone and thiochromanone derivatives |
| 09/25/2002 | EP0910398B1 Method of stimulating cilia |
| 09/25/2002 | EP0904087B1 Phosphatidic acid-comprising compositions |
| 09/25/2002 | EP0702551B1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 09/25/2002 | CN1371374A Substituted heterocycle fused gamma-carbolines |
| 09/25/2002 | CN1371372A Novel chalcones |
| 09/25/2002 | CN1371371A Novel derivatives of flavones, xanthones and coumarins |
| 09/25/2002 | CN1371370A Chalcone coumarins |
| 09/25/2002 | CN1371367A Phenethyl-5-bromopyridyl thiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
| 09/25/2002 | CN1371365A Piperidine alcohols |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/25/2002 | CN1370594A Chinese mediicne for treating women's menalgia, pelvic infection and vaginitis |
| 09/25/2002 | CN1370580A Chinese medicine for treating chronic salpingitis |
| 09/25/2002 | CN1370576A Medicine ointment for treating women's leukoplakia vulvae and valval pruritus |
| 09/25/2002 | CN1370563A Production process of waist strengthening and kidney invigorating medicated wine |
| 09/25/2002 | CN1370533A Application of new benzothiophene compound in preventing and treating women's post-menopause syndrome and other estrogen relative diseases |
| 09/25/2002 | CN1091377C Labor inducing oral liquid and preparing process thereof |
| 09/24/2002 | US6455734 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 09/24/2002 | US6455572 Estrogen agonist/antagonist metabolites |
| 09/24/2002 | US6455567 Treating dermatological disorders by administering a 3-(pyrrolidin-2-ylmethyl)-5-(aminosulfonylmethyl)indole |
| 09/24/2002 | US6455564 Oral administration of (5r)-(methylamino)-5,6-dihydro-4h-imidazo(4,5,1-ij)quinolin-2( '1h)-one or -thione |
| 09/24/2002 | US6455562 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/24/2002 | US6455542 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/24/2002 | US6455534 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 09/24/2002 | US6455525 Heterocyclic substituted pyrazolones |
| 09/24/2002 | US6455516 Administering epiallopregnanolone as antidepressant, cognition activator, or antiepileptic agent; treatment of premenstrual syndrome |
| 09/24/2002 | US6455077 Solvent extraction of herbs |
| 09/24/2002 | US6455076 Formulations and methods for reducing skin irritation |
| 09/24/2002 | CA2106683C Inactivating enveloped viruses and sperm |
| 09/20/2002 | WO2001070704A1 Novel imidazole derivatives with anti-inflammatory activity |
| 09/20/2002 | CA2403732A1 Novel imidazole derivatives with anti-inflammatory activity |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072802A2 Live attenuated strains of prrs virus |
| 09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 09/19/2002 | WO2002072626A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 09/19/2002 | WO2002072586A1 Pyrazolo'4,3-d-pyrimidine for inhibiting cgmp pde |
| 09/19/2002 | WO2002072202A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 09/19/2002 | WO2002072106A2 Combined method for treating hormono-dependent disorders with exemestane |
| 09/19/2002 | WO2002072100A2 Pharmaceutical composition containing pde v inhibitors and surfactants |
| 09/19/2002 | WO2002059109A3 Naphthostyril derivatives and their use as inhibitors of cyclin- dependent kinases |
| 09/19/2002 | WO2002036140A3 Use of a preparation of cimicifuga racemosa |
| 09/19/2002 | WO2002004487A3 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/19/2002 | WO2002002189A3 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 09/19/2002 | WO2001072702A3 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/19/2002 | WO2001016139A9 Androgen receptor modulator compounds and methods |
| 09/19/2002 | WO2001007483A9 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |